Press-release for stocks

Prices are updated after-hours

crawled time : 10:00

save search

Ascent Solar Selected By Momentus to Produce Flexible CIGS Space-Qualifiable Laminated PV Modules for Upcoming Space Flight
Published: 2022-01-31 (Crawled : 10:00) - globenewswire.com
ASTI | $0.102 -0.39% -0.39% 2.4M

Manufacturing

| 2400.0% | O: 382650.0% H: 63.29% C: -19.99%
solar space spac

View, Inc. Completes Reverse Stock Split
Published: 2023-07-27 (Crawled : 10:00) - globenewswire.com
VIEW | $0.51 -41.18% 2.4M

| 301.57% | O: 6002.36% H: 53.29% C: 41.94%

Bionomics Announces Positive Topline Results from the Phase 2b ATTUNE Clinical Trial of BNC210 in Patients with Post-Traumatic Stress Disorder (PTSD)
Published: 2023-09-28 (Crawled : 10:00) - globenewswire.com
BNOX | $0.9201 -4.15% -4.33% 43K

n/a

| -6.6% | O: 480.71% H: 12.06% C: -41.08%
bnc210 positive topline trial results

Intellipharmaceutics Announces Fiscal Year 2022 and First Quarter 2023 Results
Published: 2023-06-06 (Crawled : 10:00) - intellipharmaceutics.com
IPCIF | $0.12 -29.49% 2.8K

Health Technology

| 500.0% | O: 350.0% H: 0.0% C: 0.0%
year results

Aurora Mobile Partners with Kuaishou to Improve Monetization Efficiency
Published: 2021-02-05 (Crawled : 10:00) - globenewswire.com
JG | $3.01 0.0% 440

Technology Services

| -21.11% | O: 175.63% H: 0.27% C: -54.6%
mobile

In Akero Therapeutics’ Phase 2b HARMONY Study, Both the 50mg and 28mg EFX Doses Achieved Statistical Significance on Primary and Secondary Histology Endpoints after 24 Weeks
Published: 2022-09-13 (Crawled : 10:00) - ir.akerotx.com
AKRO | $21.02 1.11% 1.09% 560K

Health Technology

| 71.15% | O: 128.52% H: 6.21% C: 3.6%
phase 2b

First Wave BioPharma Announces Exclusive Global License Agreement for Capeserod from Sanofi
Published: 2023-09-14 (Crawled : 10:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -12.3% | O: 2.14% H: 0.0% C: -1.3%
FWBI | $2.93 0.69% 0.68% 150K

Manufacturing

| -64.15% | O: 109.38% H: 21.84% C: -44.24%
SNY | News | $47.69 1.15% 1.13% 1.7M

Health Technology

| -12.06% | O: 0.26% H: 0.74% C: 0.33%
license biopharma global agreement sanofi

Triterras Announces Collaboration with Card Cutters
Published: 2024-01-30 (Crawled : 10:00) - globenewswire.com
TRIRF | $0.0051 0.0% 1.4K

n/a

| -9.09% | O: 81.82% H: 0.0% C: -45.0%
collaboration

Important Milestone Reached for Evaxion Biotech’s EVX-01 Personalized Cancer Therapy
Published: 2022-09-21 (Crawled : 10:00) - globenewswire.com
EVAX | $4.08 -2.63% -2.7% 25K

Manufacturing

| 117.89% | O: 71.05% H: 8.3% C: -28.31%
evx-01 therapy cancer milestone

ALX Oncology Reports Positive Interim Phase 2 ASPEN-06 Clinical Trial Results of Evorpacept for the Treatment of Advanced HER2-Positive Gastric Cancer
Published: 2023-10-03 (Crawled : 10:00) - globenewswire.com
LLY | News | $745.69 1.96% -0.16% 2M

Health Technology

| 39.11% | O: 0.19% H: 0.0% C: 0.0%
ALXO M | $15.5 8.92% 8.19% 440K

Commercial Services

| 222.25% | O: 68.19% H: 2.84% C: -7.17%
aspen-06 positive cancer treatment trial results

Yunji Announces First Quarter 2023 Unaudited Financial Results
Published: 2023-06-02 (Crawled : 10:00) - prnewswire.com
YJ | $0.743 -0.11% 3.3K

Retail Trade

| 258.32% | O: 67.52% H: 63.24% C: -9.94%
financial results

QuantaSing to Report Third Fiscal Quarter Financial Results on June 1, 2023
Published: 2023-05-24 (Crawled : 10:00) - globenewswire.com
QSG | $3.335 1.68% 1.65% 69K

n/a

| -59.88% | O: 61.33% H: 0.0% C: 0.0%
report financial results

Immunovant Announces Positive Initial IMVT-1402 Phase 1 SAD and 300 mg Subcutaneous MAD Results
Published: 2023-09-26 (Crawled : 10:00) - globenewswire.com
IMVT S | $28.65 -0.31% -0.31% 1.1M

Health Technology

| 41.07% | O: 59.22% H: 29.2% C: 23.75%
imvt-1402 positive results

Roivant Announces Positive Initial IMVT-1402 Phase 1 SAD and 300 mg Subcutaneous MAD Results
Published: 2023-09-26 (Crawled : 10:00) - globenewswire.com
ROIV | $10.935 3.16% 3.06% 5M

Manufacturing

| 7.15% | O: 15.57% H: 8.73% C: 5.17%
IMVT S | $28.65 -0.31% -0.31% 1.1M

Health Technology

| 41.07% | O: 59.22% H: 29.2% C: 23.75%
imvt-1402 positive results

Immuron Announces FDA Removed Clinical Hold on New Campylobacter ETEC Therapeutic Paves way for Clinical Trial Initiation
Published: 2023-05-08 (Crawled : 10:00) - globenewswire.com
IMRN | $2.6015 4.94% 1.9K

Health Technology

| 31.55% | O: 57.75% H: 8.81% C: -9.15%
fda trial

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2023-09-11 (Crawled : 10:00) - globenewswire.com
CRNX G | $44.21 1.77% 1.74% 610K

Health Technology

| 176.89% | O: 57.06% H: 17.41% C: 3.98%
nasdaq pharmaceuticals grants

U Power To Launch Commercial Operation for its EV Battery Swapping System
Published: 2024-04-08 (Crawled : 10:00) - prnewswire.com
UCAR | $5.2 7.0% 6.54% 170K

| 2.58% | O: 56.35% H: 9.52% C: -31.85%
battery system for commercial

ZeroFox Partners with Google Cloud to Disrupt Phishing Attacks and Malicious URLs
Published: 2023-04-11 (Crawled : 10:00) - globenewswire.com
ZFOX | $1.135 -0.44% -0.44% 62K

| -30.91% | O: 55.15% H: 5.47% C: -22.27%
cloud

Telesat Contracts MDA as Prime Satellite Manufacturer for Its Advanced Telesat Lightspeed Low Earth Orbit Constellation
Published: 2023-08-11 (Crawled : 10:00) - globenewswire.com
TSAT | $7.97 0.63% 0.63% 27K

| -9.11% | O: 53.85% H: 6.85% C: -0.23%
lightspeed satellite prime

Telesat Reports Results for the Quarter and Six Months Ended June 30, 2023
Published: 2023-08-11 (Crawled : 10:00) - globenewswire.com
TSAT | $7.97 0.63% 0.63% 27K